Zobrazeno 1 - 10
of 118
pro vyhledávání: '"William R. Lenderking"'
Autor:
William R. Lenderking, Yulia Savva, Mark J. Atkinson, Renee Campbell, Isabelle Chabot, Margaret Moline, Genevieve Meier, Charles M. Morin
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-12 (2024)
Abstract Background The Insomnia Severity Index (ISI) is a widely used measure of insomnia severity. Various ISI research findings suggest different factor solutions and meaningful within-individual change (MWIC) to detect treatment response in patie
Externí odkaz:
https://doaj.org/article/7f9f97c9d0c94205b47b1870f1dab97e
Autor:
William R. Lenderking, Mark J. Atkinson, Mary Kate Ladd, Yulia Savva, Stephanie Sommer, Matthew Sidovar, Claudia Hastedt
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Background Cognitive impairment associated with schizophrenia (CIAS) represents a distinct, persistent, and core group of schizophrenia symptoms. Cognitive symptoms have been shown to have an impact on quality of life. There are several publ
Externí odkaz:
https://doaj.org/article/a2edf1ac7893498dbb640e35f209f41b
Autor:
Valeria Tellone, Oto Markovic, Milena Strashimirova, Gabriele Sani, William R. Lenderking, Mary Kay Margolis, Raffaella Fallone, Elisa Quarchioni, Agnese Cattaneo, Alessandro Comandini
Publikováno v:
Brain and Behavior, Vol 14, Iss 7, Pp n/a-n/a (2024)
Abstract Background Health‐related quality of life (HRQL) is an important goal for patients with major depressive disorder (MDD), but whether antidepressants improve HRQL in these patients is unclear. Here, we describe the real‐world effects of t
Externí odkaz:
https://doaj.org/article/63739e2db0144b489cfa53e4cd186ac0
Autor:
Caroline M. Tanner, Stanley N. Caroff, Andrew J. Cutler, William R. Lenderking, Huda Shalhoub, Véronique Pagé, Ericha G. Franey, Michael Serbin, Chuck Yonan
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-11 (2023)
Abstract Background Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with antipsychotic use. Data from RE-KINECT, a real-world study of antipsychotic-treated outpatients, were analyzed to assess the effec
Externí odkaz:
https://doaj.org/article/7624d1f68f3346d79bebd79e645eff49
Autor:
Yanyan Zhu, Milenka Jean‐Baptiste, William R. Lenderking, Jill A. Bell, Dennis A. Revicki, Huamao M. Lin, Rachael Brake, Bryce B. Reeve
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 5494-5505 (2023)
Abstract Objective Tolerability and safety of treatments are important in oncology trials and should be informed by patient assessments. We identified the most relevant patient‐reported symptomatic adverse events (AEs) to measure in patients with n
Externí odkaz:
https://doaj.org/article/3419abaa721f4c988a745640dd27f47b
Autor:
David Cella, William R. Lenderking, Peter Chongpinitchai, Andrew G. Bushmakin, Oluwaseyi Dina, Lisy Wang, Joseph C. Cappelleri, Victoria Navarro-Compán
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-10 (2022)
Plain English summary Ankylosing spondylitis (AS) is a disease that causes pain and stiffness in the spine. AS is a chronic disease. Most people with AS experience fatigue (a feeling of being very tired or exhausted). People with more severe AS tend
Externí odkaz:
https://doaj.org/article/6e9e80fde3c949509ec55f332601f2dc
Autor:
William R. Lenderking, Milena Anatchkova, Robin Pokrzywinski, Anne Skalicky, Mona L. Martin, Heather Gelhorn
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-7 (2021)
Abstract Background There has been a growing emphasis on health-related quality of life (HRQoL) as an important outcome in rare disease drug development, although its assessment may be useful outside the drug development context, including in clinica
Externí odkaz:
https://doaj.org/article/33e20763b7ad4099b3574a7557381c8e
Autor:
Gahan Pandina, Seth Ness, Jeremiah Trudeau, Sonja Stringer, Naomi Knoble, William R. Lenderking, Abigail Bangerter
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Purpose The Autism Behavior Inventory (ABI) is an observer-reported outcome scale measuring core and associated features of autism spectrum disorder (ASD). Extensive scale development (reported elsewhere) took place, in alignment with the Fo
Externí odkaz:
https://doaj.org/article/f45b64f8a6ea4deab785a528f7fd5f7d
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-10 (2020)
Abstract Background Smoldering multiple myeloma (SMM) is an early form of multiple myeloma (MM). SMM is typically considered asymptomatic, and research on how it affects health-related quality of life (HRQoL) is limited. This study assessed the sympt
Externí odkaz:
https://doaj.org/article/889e91f235e14831b73bca7a96b06abd
Autor:
Rajiv Tandon, William R. Lenderking, Catherine Weiss, Huda Shalhoub, Carla Dias Barbosa, Jun Chen, Mallik Greene, Stine R. Meehan, Laëtitia Bouérat Duvold, Celso Arango, Ofer Agid, David Castle
Publikováno v:
Annals of General Psychiatry, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background It is well established that the different antipsychotics used for schizophrenia symptoms differ substantially in their side effects. However, relatively little is known about the impact of these side effects on functioning from th
Externí odkaz:
https://doaj.org/article/bece864b6416452089021ed40c991489